| No. | Position | Ref | Alt | Gene Symbol | Heteroplasmy Levels | MITOMAP Disease Clinical Information | MITOMAP Disease Clinical Status | Filter | References | Details |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 19 | C | A | . | 0.049 | . | . | weak_evidence | No References | Variant Details |
| 2 | 73 | A | G | . | 0.978 | . | . | PASS | No References | Variant Details |
| 3 | 187 | G | C | . | 0.045 | . | . | weak_evidence | No References | Variant Details |
| 4 | 189 | A | G | . | 0.046 | . | . | weak_evidence | No References | Variant Details |
| 5 | 263 | A | G | . | 0.971 | . | . | PASS | No References | Variant Details |
| 6 | 290 | - | AT | . | 0.968 | . | . | PASS | No References | Variant Details |
| 7 | 310 | - | C | . | 0.967 | . | . | blacklisted_site | No References | Variant Details |
| 8 | 489 | T | C | . | 0.954 | . | . | PASS | No References | Variant Details |
| 9 | 527 | C | T | . | 0.133 | . | . | weak_evidence | No References | Variant Details |
| 10 | 567 | - | CCCC | . | 0.224 | . | . | weak_evidence | No References | Variant Details |
| 11 | 709 | G | A | . | 0.962 | . | . | PASS | No References | Variant Details |
| 12 | 750 | A | G | . | 0.960 | . | . | PASS | No References | Variant Details |
| 13 | 930 | G | C | . | 0.966 | . | . | PASS | No References | Variant Details |
| 14 | 1311 | C | A | . | 0.048 | . | . | weak_evidence | No References | Variant Details |
| 15 | 1418 | G | A | . | 0.052 | . | . | weak_evidence | No References | Variant Details |
| 16 | 1438 | A | G | . | 0.974 | . | . | PASS | No References | Variant Details |
| 17 | 1598 | G | A | . | 0.973 | . | . | PASS | No References | Variant Details |
| 18 | 1842 | A | G | . | 0.951 | . | . | PASS | No References | Variant Details |
| 19 | 2478 | G | A | . | 0.002 | . | . | weak_evidence | No References | Variant Details |
| 20 | 2702 | G | A | . | 0.001 | . | . | PASS | No References | Variant Details |
| 21 | 2706 | A | G | . | 1.000 | . | . | PASS | No References | Variant Details |
| 22 | 2746 | T | C | . | 1.000 | . | . | PASS | No References | Variant Details |
| 23 | 3283 | G | T | . | 0.047 | . | . | weak_evidence | No References | Variant Details |
| 24 | 3355 | A | G | MT-ND1 | 0.055 | . | . | weak_evidence | References (1) | Variant Details |
| 25 | 3376 | G | C | MT-ND1 | 0.050 | . | . | weak_evidence | No References | Variant Details |
| 26 | 3476 | C | T | MT-ND1 | 0.050 | . | . | weak_evidence | References (1) | Variant Details |
| 27 | 3978 | C | A | MT-ND1 | 0.064 | . | . | weak_evidence | No References | Variant Details |
| 28 | 4051 | G | A | MT-ND1 | 0.096 | . | . | base_qual;weak_evidence | No References | Variant Details |
| 29 | 4206 | A | G | . | 0.133 | . | . | weak_evidence | No References | Variant Details |
| 30 | 4529 | A | G | . | 0.930 | . | . | PASS | No References | Variant Details |
| 31 | 4693 | T | C | MT-ND2 | 0.100 | . | . | weak_evidence | No References | Variant Details |
| 32 | 4769 | A | G | . | 0.932 | . | . | PASS | No References | Variant Details |
| 33 | 4849 | G | A | MT-ND2 | 0.077 | . | . | weak_evidence | No References | Variant Details |
| 34 | 5880 | A | G | . | 0.064 | . | . | weak_evidence | No References | Variant Details |
| 35 | 6263 | C | A | . | 0.034 | . | . | weak_evidence | No References | Variant Details |
| 36 | 6266 | A | C | . | 0.034 | . | . | weak_evidence | No References | Variant Details |
| 37 | 7028 | C | T | . | 0.966 | . | . | PASS | No References | Variant Details |
| 38 | 7627 | C | T | . | 0.069 | . | . | weak_evidence | No References | Variant Details |
| 39 | 7712 | T | C | MT-CO2 | 0.054 | . | . | weak_evidence | No References | Variant Details |
| 40 | 8206 | G | T | MT-CO2 | 0.060 | . | . | weak_evidence | References (1) | Variant Details |
| 41 | 8701 | A | G | MT-ATP6 | 0.965 | . | . | PASS | References (102) | Variant Details |
| 42 | 8860 | A | G | MT-ATP6 | 0.903 | . | . | PASS | References (124) | Variant Details |
| 43 | 9540 | T | C | . | 0.980 | . | . | PASS | No References | Variant Details |
| 44 | 9790 | C | A | . | 0.071 | . | . | weak_evidence | No References | Variant Details |
| 45 | 10319 | A | G | . | 0.963 | . | . | PASS | No References | Variant Details |
| 46 | 10338 | T | G | MT-ND3 | 0.075 | . | . | weak_evidence | No References | Variant Details |
| 47 | 10346 | C | A | MT-ND3 | 0.073 | . | . | weak_evidence | No References | Variant Details |
| 48 | 10398 | A | G | MT-ND3 | 0.955 | PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy | Reported; lineage L & M marker, also hg IJK | PASS | References (221) | Variant Details |
| 49 | 10400 | C | T | . | 0.955 | . | . | PASS | No References | Variant Details |
| 50 | 10691 | C | A | . | 0.086 | . | . | weak_evidence | No References | Variant Details |
| 51 | 10873 | T | C | . | 0.964 | . | . | PASS | No References | Variant Details |
| 52 | 10980 | C | A | MT-ND4 | 0.051 | . | . | weak_evidence | No References | Variant Details |
| 53 | 11065 | AC | - | . | 0.055 | . | . | weak_evidence | No References | Variant Details |
| 54 | 11089 | C | T | . | 0.055 | . | . | weak_evidence | No References | Variant Details |
| 55 | 11213 | T | C | MT-ND4 | 0.051 | . | . | weak_evidence | No References | Variant Details |
| 56 | 11642 | G | T | MT-ND4 | 0.058 | . | . | weak_evidence | No References | Variant Details |
| 57 | 11719 | G | A | . | 0.968 | . | . | PASS | No References | Variant Details |
| 58 | 11914 | G | A | . | 0.966 | . | . | PASS | No References | Variant Details |
| 59 | 12087 | C | A | MT-ND4 | 0.049 | . | . | weak_evidence | No References | Variant Details |
| 60 | 12417 | - | A | . | 0.066 | . | . | weak_evidence | No References | Variant Details |
| 61 | 12635 | T | C | MT-ND5 | 0.064 | . | . | weak_evidence | No References | Variant Details |
| 62 | 12705 | C | T | . | 0.962 | . | . | PASS | No References | Variant Details |
| 63 | 12835 | G | A | MT-ND5 | 0.044 | . | . | weak_evidence | No References | Variant Details |
| 64 | 12973 | C | T | . | 0.952 | . | . | PASS | No References | Variant Details |
| 65 | 13022 | T | G | MT-ND5 | 0.034 | . | . | weak_evidence | No References | Variant Details |
| 66 | 13062 | A | G | . | 0.030 | . | . | weak_evidence | No References | Variant Details |
| 67 | 13368 | G | A | . | 0.052 | . | . | weak_evidence | No References | Variant Details |
| 68 | 14081 | G | A | MT-ND5 | 0.047 | . | . | weak_evidence | No References | Variant Details |
| 69 | 14106 | T | C | . | 0.045 | . | . | weak_evidence | No References | Variant Details |
| 70 | 14470 | T | C | . | 0.974 | . | . | PASS | No References | Variant Details |
| 71 | 14528 | C | A | MT-ND6 | 0.079 | . | . | weak_evidence | No References | Variant Details |
| 72 | 14544 | G | A | . | 0.955 | . | . | PASS | No References | Variant Details |
| 73 | 14766 | C | T | MT-CYB | 0.971 | . | . | PASS | References (113) | Variant Details |
| 74 | 14783 | T | C | . | 0.975 | . | . | PASS | No References | Variant Details |
| 75 | 14833 | A | C | . | 0.049 | . | . | weak_evidence | No References | Variant Details |
| 76 | 14864 | T | C | MT-CYB | 0.049 | MELAS | Reported | weak_evidence | References (1) | Variant Details |
| 77 | 15043 | G | A | . | 0.976 | . | . | PASS | No References | Variant Details |
| 78 | 15236 | A | G | MT-CYB | 0.036 | Possible LHON helper (one 11778 patient) | Reported | weak_evidence | References (21) | Variant Details |
| 79 | 15301 | G | A | . | 0.979 | . | . | PASS | No References | Variant Details |
| 80 | 15326 | A | G | MT-CYB | 0.978 | . | . | PASS | References (116) | Variant Details |
| 81 | 15479 | T | C | MT-CYB | 0.043 | . | . | weak_evidence | References (4) | Variant Details |
| 82 | 15517 | C | T | . | 0.980 | . | . | PASS | No References | Variant Details |
| 83 | 15613 | A | T | . | 0.040 | . | . | weak_evidence | No References | Variant Details |
| 84 | 16180 | A | - | . | 0.092 | . | . | weak_evidence | No References | Variant Details |
| 85 | 16182 | A | C | . | 0.499 | . | . | blacklisted_site | No References | Variant Details |
| 86 | 16183 | A | C | . | 0.506 | . | . | PASS | No References | Variant Details |
| 87 | 16189 | T | C | . | 0.959 | . | . | PASS | No References | Variant Details |
| 88 | 16209 | T | C | . | 0.960 | . | . | PASS | No References | Variant Details |
| 89 | 16223 | C | T | . | 0.959 | . | . | PASS | No References | Variant Details |
| 90 | 16519 | T | C | . | 0.970 | . | . | PASS | No References | Variant Details |
| No. | Position | Ref | Alt | Gene Symbol | Heteroplasmy Levels | MITOMAP Disease Clinical Information | MITOMAP Disease Clinical Status | Filter | References | Details |